ARCHIVES

Zerhouni Appoints Kington As Deputy Director

This article is from The Cancer Letter archive.

Vol. 29 No. 07 | February 14, 2003

Download PDF Visit The Full Archive

Related Articles

Analysis Reveals CAIX Subgroup Responsive to Rencarex Therapy

June 28, 2013

New NCAB Weak In Grant Reviews, Confused By Issues

December 10, 1982

Other Concepts Approves By DCE Board Last Week

June 20, 1986

Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk

December 26, 2014

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012

Group Chairmen Propose Adding Four Trials For High Priority Status

July 6, 1990